$1.76 Billion is the total value of Perceptive Advisors's 173 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 70.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
NBIX | Buy | NEUROCRINE BIOSCIENCES SHARES | $145,771,000 | +13.6% | 3,366,530 | +1.5% | 8.30% | -9.0% |
GBT | Buy | GLOBAL BLOOD THERAPEUTICS SHARES | $142,203,000 | +214.5% | 3,858,978 | +23.3% | 8.10% | +152.0% |
FOLD | AMICUS THERAPEUTICS SHARES | $123,325,000 | +43.5% | 17,296,672 | 0.0% | 7.02% | +14.9% | |
VSAR | Buy | VERSARTIS SHARES | $94,096,000 | +52.0% | 4,407,317 | +6.1% | 5.36% | +21.8% |
LJPC | Buy | LA JOLLA PHARMACEUTICAL SHARES | $63,857,000 | +176.1% | 2,139,274 | +62.2% | 3.64% | +121.2% |
ALNY | Buy | ALNYLAM PHARMACEUTICALS SHARES | $56,553,000 | +1174.9% | 1,103,475 | +831.4% | 3.22% | +922.9% |
SRPT | Sell | SAREPTA THERAPEUTICS SHARES | $52,422,000 | -31.0% | 1,771,029 | -36.1% | 2.99% | -44.7% |
RTRX | Buy | RETROPHIN SHARES | $51,826,000 | +1.9% | 2,807,525 | +4.5% | 2.95% | -18.4% |
NXTM | Sell | NXSTAGE MEDICAL SHARES | $48,782,000 | -3.5% | 1,818,189 | -5.7% | 2.78% | -22.7% |
XNCR | Sell | XENCOR SHARES | $38,440,000 | -18.2% | 1,607,018 | -10.0% | 2.19% | -34.5% |
ACRS | ACLARIS THERAPEUTICS SHARES | $37,598,000 | +9.9% | 1,260,847 | 0.0% | 2.14% | -12.0% | |
TSRO | Sell | TESARO SHARES | $37,087,000 | -59.9% | 241,028 | -65.0% | 2.11% | -67.9% |
VBIV | VBI VACCINES SHARES | $36,046,000 | +77.1% | 6,565,843 | 0.0% | 2.05% | +41.9% | |
RDUS | Buy | RADIUS HEALTH SHARES | $35,205,000 | +250.8% | 910,872 | +245.2% | 2.00% | +180.8% |
AVXS | Sell | AVEXIS SHARES | $34,100,000 | +50.9% | 448,501 | -5.3% | 1.94% | +20.8% |
EVH | Buy | EVOLENT HEALTH SHARES CLASS A | $32,212,000 | +607.2% | 1,444,500 | +369.3% | 1.84% | +466.4% |
VRTX | Buy | VERTEX PHARMACEUTICALS SHARES | $32,095,000 | +409.5% | 293,509 | +243.2% | 1.83% | +308.0% |
RGNX | Buy | REGENXBIO SHARES | $26,947,000 | +13.3% | 1,396,244 | +8.9% | 1.54% | -9.2% |
LBIO | LION BIOTECHNOLOGIES SHARES | $26,578,000 | +7.2% | 3,567,553 | 0.0% | 1.51% | -14.1% | |
CTMX | Buy | CYTOMX THERAPEUTICS SHARES | $26,434,000 | +160.4% | 1,530,659 | +65.7% | 1.51% | +108.6% |
ANAB | New | ANAPTYSBIO SHARES | $24,474,000 | – | 881,957 | +100.0% | 1.39% | – |
ZGNX | Buy | ZOGENIX SHARES | $23,906,000 | +161.3% | 2,203,302 | +192.6% | 1.36% | +109.2% |
ARDX | Buy | ARDELYX SHARES | $23,860,000 | -8.5% | 1,886,196 | +2.7% | 1.36% | -26.7% |
GLPG | Sell | GALAPAGOS ADR REPRESENTING SHARES | $23,392,000 | +13.4% | 271,405 | -10.9% | 1.33% | -9.1% |
DBVT | Sell | DBV TECHNOLOGIES ADR REPRESENTING 0.5 SHARES | $20,842,000 | -2.8% | 591,765 | -3.1% | 1.19% | -22.2% |
NVRO | New | NEVRO SHARES | $20,360,000 | – | 217,292 | +100.0% | 1.16% | – |
QTNT | Buy | QUOTIENT SHARES | $20,372,000 | +47.5% | 2,917,785 | +2.2% | 1.16% | +18.1% |
KDMN | Buy | KADMON SHARES | $18,772,000 | +58.8% | 5,185,847 | +134.7% | 1.07% | +27.1% |
BPMC | Buy | BLUEPRINT MEDICINES SHARES | $18,461,000 | +140.4% | 461,642 | +68.6% | 1.05% | +92.7% |
WVE | WAVE LIFE SCIENCES SHARES | $18,293,000 | +1.1% | 665,198 | 0.0% | 1.04% | -19.0% | |
XLRN | Buy | ACCELERON PHARMA SHARES | $17,572,000 | +11.1% | 663,857 | +7.1% | 1.00% | -11.0% |
ACRX | ACELRX PHARMACEUTICALS SHARES | $17,037,000 | +21.1% | 5,408,728 | 0.0% | 0.97% | -2.9% | |
ASMB | Sell | ASSEMBLY BIOSCIENCES SHARES | $16,934,000 | +95.1% | 664,354 | -7.0% | 0.96% | +56.4% |
AVDL | Buy | AVADEL PHARMACEUTICALS ADR | $13,632,000 | -5.5% | 1,408,240 | +1.4% | 0.78% | -24.3% |
ALDX | Buy | ALDEYRA THERAPEUTICS SHARES | $12,897,000 | +24.2% | 2,885,458 | +48.7% | 0.74% | -0.4% |
ANIP | Sell | ANI PHARMACEUTICALS SHARES | $12,620,000 | -22.1% | 254,889 | -4.6% | 0.72% | -37.5% |
AMAG | Buy | AMAG PHARMACEUTICALS SHARES | $12,628,000 | +1759.8% | 560,000 | +2768.3% | 0.72% | +1397.9% |
CORI | New | CORIUM INTERNATIONAL SHARES | $11,096,000 | – | 2,654,485 | +100.0% | 0.63% | – |
ABMD | Buy | ABIOMED SHARES | $10,642,000 | +88583.3% | 85,000 | +77881.7% | 0.61% | +60500.0% |
CRBP | CORBUS PHARMACEUTICALS HOLDINGS SHARES | $10,312,000 | -2.4% | 1,250,000 | 0.0% | 0.59% | -21.8% | |
IRTC | Sell | IRHYTHM TECHNOLOGIES SHARES | $10,192,000 | -3.5% | 271,057 | -23.0% | 0.58% | -22.6% |
CLVS | Sell | CLOVIS ONCOLOGY SHARES | $10,044,000 | +34.8% | 157,754 | -6.0% | 0.57% | +7.9% |
BIO | Buy | BIO RAD LABORATORIES SHARES CLASS A | $9,851,000 | +121.3% | 49,416 | +102.4% | 0.56% | +77.0% |
EXAS | New | EXACT SCIENCES SHARES | $9,684,000 | – | 410,000 | +100.0% | 0.55% | – |
ATRS | ANTARES PHARMA SHARES | $8,285,000 | +21.9% | 2,917,253 | 0.0% | 0.47% | -2.3% | |
MYOK | MYOKARDIA SHARES | $8,214,000 | +1.5% | 624,694 | 0.0% | 0.47% | -18.6% | |
CSU | Buy | CAPITAL SENIOR LIVING SHARES | $8,087,000 | +54.9% | 575,173 | +79.6% | 0.46% | +24.3% |
ALDR | ALDER BIOPHARMACEUTICALS SHARES | $7,991,000 | 0.0% | 384,169 | 0.0% | 0.46% | -19.9% | |
ANI PHARMACEUTICALS INC 01DEC19 3.0PCTnote | $7,958,000 | -8.5% | 7,500,000 | 0.0% | 0.45% | -26.8% | ||
FWP | Sell | FORWARD PHARMA ADR REPRESENTING 1 SHARES | $7,634,000 | +29.0% | 354,241 | -10.1% | 0.44% | +3.3% |
QURE | UNIQURE SHARES | $7,317,000 | +3.2% | 1,265,963 | 0.0% | 0.42% | -17.3% | |
NERV | MINERVA NEUROSCIENCES INC | $6,565,000 | -31.1% | 810,537 | 0.0% | 0.37% | -44.8% | |
FOMX | FOAMIX PHARMACEUTICALS SHARES | $6,549,000 | -55.4% | 1,322,994 | 0.0% | 0.37% | -64.3% | |
CDTX | Buy | CIDARA THERAPEUTICS SHARES | $6,445,000 | -19.9% | 826,369 | +6.9% | 0.37% | -35.8% |
VIVE | New | VIVEVE MEDICAL SHARES | $5,942,000 | – | 938,742 | +100.0% | 0.34% | – |
SRRA | New | SIERRA ONCOLOGY SHARES | $5,667,000 | – | 3,703,704 | +100.0% | 0.32% | – |
HUM | Buy | HUMANA SHARES | $5,669,000 | +1148.7% | 27,500 | +1134.8% | 0.32% | +909.4% |
CLSD | CLEARSIDE BIOMEDICAL SHARES | $5,653,000 | -11.2% | 712,062 | 0.0% | 0.32% | -28.9% | |
NVTA | Sell | INVITAE SHARES | $5,309,000 | +33.7% | 480,000 | -4.0% | 0.30% | +7.1% |
PFNX | Sell | PFENEX SHARES | $5,187,000 | -37.5% | 892,847 | -2.4% | 0.30% | -50.0% |
ZYNE | Sell | ZYNERBA PHARMACEUTICALS INC | $5,051,000 | -61.5% | 251,328 | -70.2% | 0.29% | -69.2% |
AXGT | New | AXOVANT SCIENCES SHARES | $4,631,000 | – | 310,000 | +100.0% | 0.26% | – |
NEPT | NEPTUNE TECHNOLOGIES AND BIORESOURCES SHARES | $4,610,000 | -23.2% | 6,519,634 | 0.0% | 0.26% | -38.4% | |
SGYPQ | Buy | SYNERGY PHARMACEUTICALS SHARES | $4,558,000 | +52.6% | 978,100 | +99.5% | 0.26% | +22.6% |
JAZZ | Sell | JAZZ PHARMACEUTICALS SHARES | $4,354,000 | -23.2% | 30,000 | -42.3% | 0.25% | -38.5% |
PPHMP | PEREGRINE PHARMACEUTICALS INC 10.5 | $4,342,000 | +9.0% | 200,000 | 0.0% | 0.25% | -12.7% | |
DERM | Sell | DERMIRA SHARES | $3,943,000 | -60.1% | 115,583 | -64.5% | 0.22% | -67.9% |
PSDV | PSIVIDA SHARES | $3,921,000 | +0.6% | 2,279,706 | 0.0% | 0.22% | -19.5% | |
ABEOW | ABEONA THERAPEUTICS SHARES CW-19 | $3,690,000 | -2.3% | 1,259,636 | 0.0% | 0.21% | -21.9% | |
ADMA | ADMA BIOLOGICS SHARES | $3,519,000 | -4.7% | 721,102 | 0.0% | 0.20% | -24.0% | |
AMGN | New | AMGEN SHARES | $3,281,000 | – | 20,000 | +100.0% | 0.19% | – |
ONS | Sell | ONCOBIOLOGICS SHARES | $3,167,000 | -15.7% | 1,181,874 | -5.4% | 0.18% | -32.6% |
ABEO | Sell | ABEONA THERAPEUTICS SHARES | $3,114,000 | -23.8% | 622,873 | -26.0% | 0.18% | -39.0% |
HSGX | HISTOGENCIS CORP | $3,075,000 | +3.6% | 1,777,777 | 0.0% | 0.18% | -17.1% | |
AVEO | Buy | AVEO PHARMACEUTICALS SHARES | $3,014,000 | +79.6% | 5,108,808 | +64.3% | 0.17% | +44.5% |
XENE | Sell | XENON PHARMACEUTICALS SHARES | $2,895,000 | -49.2% | 723,853 | -2.2% | 0.16% | -59.3% |
OCRX | New | OCERA THERAPEUTICS SHARES | $2,817,000 | – | 2,150,000 | +100.0% | 0.16% | – |
MGCD | Sell | MGC DIAGNOSTICS SHARES | $2,524,000 | -3.0% | 302,327 | -8.3% | 0.14% | -22.2% |
AERI | AERIE PHARMACEUTICALS SHARES | $2,268,000 | +19.8% | 50,000 | 0.0% | 0.13% | -4.4% | |
PTLA | New | PORTOLA PHARMACEUTICALS SHARES | $2,268,000 | – | 57,870 | +100.0% | 0.13% | – |
ALQA | Buy | ALLIQUA BIOMEDICAL SHARES | $2,136,000 | +88.5% | 4,233,951 | +120.3% | 0.12% | +50.6% |
RARX | Sell | RA PHARMACEUTICALS SHARES | $2,129,000 | -15.0% | 100,000 | -39.4% | 0.12% | -32.0% |
UNH | Buy | UNITEDHEALTH GROUP SHARES | $2,132,000 | +313.2% | 13,000 | +303.4% | 0.12% | +227.0% |
SELB | SELECTA BIOSCIENCES SHARES | $2,032,000 | -16.5% | 141,875 | 0.0% | 0.12% | -32.9% | |
SAGE | New | SAGE THERAPEUTICS INC REGISTERED SHARES CALL 80 06/16/2017call | $1,966,000 | – | 200,000 | +100.0% | 0.11% | – |
IMMU | New | IMMUNOMEDICS SHARES | $1,941,000 | – | 300,060 | +100.0% | 0.11% | – |
EIGR | EIGER BIOPHARMACEUTICALS SHARES | $1,805,000 | -1.7% | 157,679 | 0.0% | 0.10% | -21.4% | |
BCLI | New | BRAINSTORM CELL THERAPEUTICS INC SHARES (OLD) | $1,700,000 | – | 400,000 | +100.0% | 0.10% | – |
AFMD | AFFIMED SHARES | $1,689,000 | +27.8% | 734,301 | 0.0% | 0.10% | +2.1% | |
ARWR | ARROWHEAD PHARMACEUTICALS SHARES | $1,567,000 | +19.3% | 847,458 | 0.0% | 0.09% | -4.3% | |
AXGT | New | AXOVANT SCIENCES LTD REGISTERED SHARES CALL 25 10/20/2017call | $1,420,000 | – | 200,000 | +100.0% | 0.08% | – |
CRIS | New | CURIS SHARES | $1,390,000 | – | 500,000 | +100.0% | 0.08% | – |
CSBR | Sell | CHAMPIONS ONCOLOGY SHARES | $1,163,000 | +23.5% | 366,972 | -1.5% | 0.07% | -1.5% |
BLCM | New | BELLICUM PHARMACEUTICALS SHARES | $1,064,000 | – | 86,200 | +100.0% | 0.06% | – |
EXEL | EXELIXIS SHARES | $1,005,000 | +45.4% | 46,361 | 0.0% | 0.06% | +16.3% | |
AKRXQ | New | AKORN SHARES | $963,000 | – | 40,000 | +100.0% | 0.06% | – |
ZSAN | New | ZOSANO PHARMA SHARES | $950,000 | – | 500,000 | +100.0% | 0.05% | – |
AZRX | AZURRX BIOPHARMA SHARES | $877,000 | -18.6% | 227,272 | 0.0% | 0.05% | -35.1% | |
INCY | INCYTE SHARES | $751,000 | +33.4% | 5,619 | 0.0% | 0.04% | +7.5% | |
WCG | Buy | WELLCARE HEALTHCARE PLANS SHARES | $741,000 | +6.9% | 5,283 | +4.5% | 0.04% | -14.3% |
FCAU | FIAT CHRYSLER AUTOMOBILES SHARES | $678,000 | +20.0% | 62,000 | 0.0% | 0.04% | -2.5% | |
HSKA | New | HESKA SHARES | $661,000 | – | 6,300 | +100.0% | 0.04% | – |
LNTH | LANTHEUS HOLDINGS SHARES | $672,000 | +45.5% | 53,763 | 0.0% | 0.04% | +15.2% | |
MTST | METASTAT SHARES | $662,000 | +7.1% | 500,000 | 0.0% | 0.04% | -13.6% | |
OSUR | New | ORASURE TECHNOLOGIES SHARES | $609,000 | – | 47,125 | +100.0% | 0.04% | – |
AKAOQ | New | ACHAOGEN SHARES | $593,000 | – | 23,496 | +100.0% | 0.03% | – |
ILMN | New | ILLUMINA SHARES | $597,000 | – | 3,500 | +100.0% | 0.03% | – |
PRTO | PROTEON THERAPEUTICS SHARES | $585,000 | -7.9% | 334,116 | 0.0% | 0.03% | -26.7% | |
MASI | New | MASIMO SHARES | $554,000 | – | 5,945 | +100.0% | 0.03% | – |
HRC | HILL ROM HOLDINGS SHARES | $560,000 | +25.8% | 7,930 | 0.0% | 0.03% | 0.0% | |
RDUS | New | RADIUS HEALTH INC REGISTERED SHARES PUT 30 07/21/2017put | $570,000 | – | 9,800 | +100.0% | 0.03% | – |
CNC | New | CENTENE SHARES | $551,000 | – | 7,726 | +100.0% | 0.03% | – |
HMSY | New | HMS HOLDINGS SHARES | $540,000 | – | 26,553 | +100.0% | 0.03% | – |
MDRX | New | ALLSCRIPTS HEALTHCARE SOLUTIONS SHARES | $545,000 | – | 42,955 | +100.0% | 0.03% | – |
PRAH | New | PRA HEALTH SCIENCES SHARES | $542,000 | – | 8,308 | +100.0% | 0.03% | – |
CBM | New | CAMBREX SHARES | $524,000 | – | 9,515 | +100.0% | 0.03% | – |
MCK | Buy | MCKESSON SHARES | $534,000 | +23.6% | 3,601 | +17.0% | 0.03% | -3.2% |
VNDA | New | VANDA PHARMACEUTICALS SHARES | $507,000 | – | 36,232 | +100.0% | 0.03% | – |
PAHC | New | PHIBRO ANIMAL HEALTH SHARES CLASS A | $517,000 | – | 18,382 | +100.0% | 0.03% | – |
QSII | New | QUALITY SYSTEMS SHARES | $516,000 | – | 33,875 | +100.0% | 0.03% | – |
ANTM | New | ANTHEM SHARES | $510,000 | – | 3,081 | +100.0% | 0.03% | – |
CUTR | New | CUTERA SHARES | $496,000 | – | 23,981 | +100.0% | 0.03% | – |
RACE | FERRARI SHARES | $461,000 | +28.1% | 6,200 | 0.0% | 0.03% | 0.0% | |
AKBA | Sell | AKEBIA THERAPEUTICS SHARES | $457,000 | -91.8% | 49,624 | -90.8% | 0.03% | -93.5% |
BLUE | New | BLUEBIRD BIO SHARES | $422,000 | – | 4,644 | +100.0% | 0.02% | – |
ONSIW | Sell | ONCOBIOLOGICS EQUITY WARRANTS SERIES A EXP 18TH FEB 2018 | $370,000 | +198.4% | 462,500 | -29.5% | 0.02% | +133.3% |
EARS | New | AURIS MEDICAL HOLDING SHARES | $368,000 | – | 400,000 | +100.0% | 0.02% | – |
QHCCQ | Sell | QUORUM HEALTH SHARES | $275,000 | -62.4% | 50,604 | -49.7% | 0.02% | -69.2% |
New | PERNIX THERAPEUTICS HOLD 01APR21 4.25PCT | $275,000 | – | 1,000,000 | +100.0% | 0.02% | – | |
LHCG | LHC GROUP SHARES | $256,000 | +18.0% | 4,745 | 0.0% | 0.02% | 0.0% | |
ACST | ACASTI PHARMA SHARES CLASS A | $254,000 | +9.0% | 186,559 | 0.0% | 0.01% | -17.6% | |
ARNI | ARNO THERAPEUTICS SHARES | $254,000 | -67.5% | 4,177,577 | 0.0% | 0.01% | -75.0% | |
ARRY | New | ARRAY BIOPHARMA SHARES | $228,000 | – | 25,510 | +100.0% | 0.01% | – |
ONSIZ | Sell | ONCOBIOLOGICS EQUITY WARRANTS SERIES B EXP 18TH MAY 2018 | $231,000 | -55.4% | 462,500 | -29.5% | 0.01% | -64.9% |
EVH | New | EVOLENT HEALTH INC SHARES -A- CALL 20 06/16/2017call | $190,000 | – | 50,000 | +100.0% | 0.01% | – |
BOLD | AUDENTES THERAPEUTICS SHARES | $128,000 | -6.6% | 7,500 | 0.0% | 0.01% | -30.0% | |
RCM | New | R1 RCM SHARES | $56,000 | – | 17,976 | +100.0% | 0.00% | – |
RXDX | IGNYTA SHARES | $57,000 | +62.9% | 6,584 | 0.0% | 0.00% | +50.0% | |
AGLE | Sell | AEGLEA BIOTHERAPEUTICS SHARES | $43,000 | -90.5% | 5,833 | -94.4% | 0.00% | -93.8% |
WST | WEST PHARMACEUTICAL SERVICES SHARES | $11,000 | -8.3% | 138 | 0.0% | 0.00% | 0.0% | |
SEVION THERAPEUTICS INC | $9,000 | +12.5% | 59,220 | 0.0% | 0.00% | 0.0% | ||
PPHM | PEREGRINE PHARMACEUTICALS SHARES | $16,000 | +100.0% | 24,332 | 0.0% | 0.00% | 0.0% | |
CBPO | CHINA BIOLOGIC PRODUCTS SHARES | $24,000 | -4.0% | 236 | 0.0% | 0.00% | -50.0% | |
ADHD | New | ALCOBRA SHARES | $10,000 | – | 9,109 | +100.0% | 0.00% | – |
AGEN | Sell | AGENUS SHARES | $14,000 | -95.3% | 3,600 | -95.0% | 0.00% | -95.2% |
EPZM | New | EPIZYME SHARES | $20,000 | – | 1,165 | +100.0% | 0.00% | – |
CAPR | CAPRICOR THERAPEUTICS SHARES | $13,000 | +18.2% | 4,000 | 0.0% | 0.00% | 0.0% | |
BMRN | BIOMARIN PHARMACEUTICAL SHARES | $22,000 | +4.8% | 250 | 0.0% | 0.00% | 0.0% | |
ABBV | New | ABBVIE SHARES | $25,000 | – | 380 | +100.0% | 0.00% | – |
ABT | Sell | ABBOTT LABORATORIES SHARES | $18,000 | -99.1% | 415 | -99.2% | 0.00% | -99.3% |
CLDX | New | CELLDEX THERAPEUTICS SHARES | $25,000 | – | 6,970 | +100.0% | 0.00% | – |
TLT | ISHARES 20 PLUS YEAR TREASURY BOND ETFnote | $0 | – | 2 | 0.0% | 0.00% | – | |
IVV | ISHARES CORE SandP 500 ETF | $0 | – | 1 | 0.0% | 0.00% | – | |
CASC | Sell | CASCADIAN THERAPEUTICS SHARES | $8,000 | -99.7% | 1,966 | -99.6% | 0.00% | -100.0% |
CERS | New | CERUS SHARES | $3,000 | – | 740 | +100.0% | 0.00% | – |
FPRX | Sell | FIVE PRIME THERAPEUTICS SHARES | $5,000 | -99.9% | 127 | -99.9% | 0.00% | -100.0% |
ACHC | New | ACADIA HEALTHCARE COMPANY SHARES | $0 | – | 1 | +100.0% | 0.00% | – |
XIV | New | CREDIT SUISSE VELOCITYSHARES DAILY INVERSE VIX SHORT TERM ET | $1,000 | – | 16 | +100.0% | 0.00% | – |
CRY | CRYOLIFE SHARES | $2,000 | 0.0% | 123 | 0.0% | 0.00% | – | |
DHR | DANAHER SHARES | $0 | – | 3 | 0.0% | 0.00% | – | |
LLY | Exit | ELI LILLY & CO CALL 90 01/20/2017call | $0 | – | -100,000 | -100.0% | 0.00% | – |
NEOS | Exit | NEOS THERAPEUTICS | $0 | – | -1,056 | -100.0% | 0.00% | – |
ATRC | Sell | ATRICURE SHARES | $1,000 | -99.9% | 55 | -99.9% | 0.00% | -100.0% |
NPCUF | ALLON THERAPEUTICS SHARES | $0 | – | 751,124 | 0.0% | 0.00% | – | |
TNGNQ | TENGION INC | $3,000 | +200.0% | 1,826,399 | 0.0% | 0.00% | – | |
TXMD | Sell | THERAPEUTICSMD SHARES | $8,000 | -99.5% | 1,081 | -99.6% | 0.00% | -100.0% |
TCON | Sell | TRACON PHARMACEUTICALS SHARES | $0 | -100.0% | 50 | -100.0% | 0.00% | -100.0% |
OPHT | New | OPHTHOTECH SHARES | $5,000 | – | 1,600 | +100.0% | 0.00% | – |
OBLN | New | OBALON THERAPEUTICS SHARES | $0 | – | 4 | +100.0% | 0.00% | – |
BSX | BOSTON SCIENTIFIC SHARES | $0 | – | 3 | 0.0% | 0.00% | – | |
AGRX | Sell | AGILE THERAPEUTICS SHARES | $0 | -100.0% | 42 | -100.0% | 0.00% | -100.0% |
IWS | ISHARES RUSSELL MID-CAP VALUE ETF | $0 | – | 2 | 0.0% | 0.00% | – | |
GNMX | Sell | AEVI GENOMIC MEDICINE SHARES | $2,000 | -99.9% | 940 | -99.7% | 0.00% | -100.0% |
TMO | Exit | THERMO FISHER SCIENTIFIC | $0 | – | -2 | -100.0% | 0.00% | – |
APVO | Sell | APTEVO THERAPEUTICS SHARES | $1,000 | -100.0% | 450 | -100.0% | 0.00% | -100.0% |
OPHT | Exit | OPHTHOTECH CORP CALL 75 01/20/2017call | $0 | – | -220,400 | -100.0% | 0.00% | – |
IPXL | Exit | IMPAX LABORATORIES | $0 | – | -1 | -100.0% | 0.00% | – |
GLD | Exit | SPDR GOLD SHARES ETF | $0 | – | -1 | -100.0% | 0.00% | – |
MRTX | Exit | MIRATI THERAPEUTICS | $0 | – | -521 | -100.0% | 0.00% | – |
ZTS | Exit | ZOETIS CLASS A | $0 | – | -3 | -100.0% | 0.00% | – |
SGMO | Exit | SANGAMO BIOSCIENCES | $0 | – | -272 | -100.0% | 0.00% | – |
AVGR | Exit | AVINGER | $0 | – | -1,062 | -100.0% | 0.00% | – |
CTLT | Exit | CATALENT | $0 | – | -3 | -100.0% | 0.00% | – |
ACAD | Exit | ACADIA PHARMACEUTICALS INC CALL 40 01/20/2017call | $0 | – | -100,000 | -100.0% | 0.00% | – |
DVA | Exit | DAVITA | $0 | – | -3 | -100.0% | 0.00% | – |
JNJ | Exit | JOHNSON and JOHNSON | $0 | – | -2 | -100.0% | 0.00% | – |
INNL | Exit | INNOCOLL | $0 | – | -9,433 | -100.0% | 0.00% | – |
FLKS | Exit | FLEX PHARMA | $0 | – | -237 | -100.0% | 0.00% | – |
CRBP | Exit | CORBUS PHARMACEUTICALS HOLDINGS INC CALL 15 01/20/2017call | $0 | – | -1,600 | -100.0% | 0.00% | – |
BRKR | Exit | BRUKER | $0 | – | -3 | -100.0% | 0.00% | – |
DIA | Exit | SPDR DOW JONES INDUSTRIAL AVERAGE ETF | $0 | – | -3 | -100.0% | 0.00% | – |
DVAX | Exit | DYNAVAX TECHNOLOGIES CALL 4 01/2017call | $0 | – | -15,600 | -100.0% | 0.00% | – |
XBI | Exit | SPDR SandP BIOTECH ETF | $0 | – | -50 | -100.0% | 0.00% | – |
GKOS | Exit | GLAUKOS | $0 | – | -300 | -100.0% | -0.00% | – |
SUPN | Exit | SUPERNUS PHARMACEUTICALS | $0 | – | -421 | -100.0% | -0.00% | – |
INGN | Exit | INOGEN | $0 | – | -125 | -100.0% | -0.00% | – |
ARIA | Exit | ARIAD PHARMACEUTICALS | $0 | – | -1,551 | -100.0% | -0.00% | – |
VCEL | Exit | VERICEL | $0 | – | -9,385 | -100.0% | -0.00% | – |
OPHT | Exit | OPHTHOTECH CORP PUT 20 01/20/2017put | $0 | – | -1,600 | -100.0% | -0.00% | – |
CEMP | Exit | CEMPRA | $0 | – | -22,321 | -100.0% | -0.00% | – |
CYNO | Exit | CYNOSURE CLASS A | $0 | – | -1,800 | -100.0% | -0.01% | – |
STML | Exit | STEMLINE THERAPEUTICS | $0 | – | -10,702 | -100.0% | -0.01% | – |
MDGWW | Exit | AEVI GENOMIC MEDICINE WARRANTwarrants | $0 | – | -150,000 | -100.0% | -0.01% | – |
PMD | Exit | PSYCHEMEDICS | $0 | – | -6,626 | -100.0% | -0.01% | – |
FVE | Exit | FIVE STAR QUALITY CARE | $0 | – | -67,797 | -100.0% | -0.01% | – |
GNVC | Exit | GENVEC | $0 | – | -56,131 | -100.0% | -0.01% | – |
MACK | Exit | MERRIMACK PHARMACEUTICALS | $0 | – | -48,910 | -100.0% | -0.01% | – |
NTLA | Exit | INTELLIA THERAPEUTICS | $0 | – | -14,673 | -100.0% | -0.01% | – |
ENDP | Exit | ENDO INTERNATIONAL | $0 | – | -12,920 | -100.0% | -0.02% | – |
PBYI | Exit | PUMA BIOTECHNOLOGY | $0 | – | -7,344 | -100.0% | -0.02% | – |
Exit | PERNIX THERAPEUTICS HOLD 01APR21 4.25PCTnote | $0 | – | -1,000,000 | -100.0% | -0.02% | – | |
SRPT | Exit | SAREPTA THERAPEUTICS INC PUT 50 01/20/2017put | $0 | – | -10,900 | -100.0% | -0.02% | – |
NVLS | Exit | NIVALIS THERAPEUTICS | $0 | – | -122,275 | -100.0% | -0.02% | – |
IRIX | Exit | IRIDEX | $0 | – | -21,885 | -100.0% | -0.02% | – |
PZRXQ | Exit | PHASERX | $0 | – | -200,000 | -100.0% | -0.02% | – |
MOH | Exit | MOLINA HEALTHCARE | $0 | – | -6,981 | -100.0% | -0.03% | – |
SCMP | Exit | SUCAMPO PHARMACEUTICALS CLASS A | $0 | – | -30,694 | -100.0% | -0.03% | – |
NVAX | Exit | NOVAVAX | $0 | – | -335,413 | -100.0% | -0.03% | – |
IMDZ | Exit | IMMUNE DESIGN | $0 | – | -77,725 | -100.0% | -0.03% | – |
ESRX | Exit | EXPRESS SCRIPTS HOLDING | $0 | – | -6,639 | -100.0% | -0.03% | – |
AGTC | Exit | APPLIED GENETIC TECHNOLOGIES | $0 | – | -50,251 | -100.0% | -0.03% | – |
AMN | Exit | AMN HEALTHCARE | $0 | – | -12,585 | -100.0% | -0.03% | – |
ICLR | Exit | ICON | $0 | – | -6,873 | -100.0% | -0.04% | – |
HUM | Exit | HUMANA INC CALL 210 04/21/2017call | $0 | – | -40,000 | -100.0% | -0.04% | – |
CCRN | Exit | CROSS COUNTRY HEALTHCARE | $0 | – | -34,819 | -100.0% | -0.04% | – |
SCYX | Exit | SCYNEXIS | $0 | – | -171,185 | -100.0% | -0.04% | – |
BIIB | Exit | BIOGEN INC | $0 | – | -1,922 | -100.0% | -0.04% | – |
MGLN | Exit | MAGELLAN HEALTH | $0 | – | -7,508 | -100.0% | -0.04% | – |
ENZ | Exit | ENZO BIOCHEM | $0 | – | -83,893 | -100.0% | -0.04% | – |
INCR | Exit | INC RESEARCH HOLDINGS CLASS A | $0 | – | -12,636 | -100.0% | -0.05% | – |
EXAS | Exit | EXACT SCIENCES CORP PUT 17 01/20/2017put | $0 | – | -200,000 | -100.0% | -0.05% | – |
UTHR | Exit | UNITED THERAPEUTICS | $0 | – | -4,753 | -100.0% | -0.05% | – |
ACHI | Exit | ACCRETIVE HEALTH | $0 | – | -315,000 | -100.0% | -0.05% | – |
BCLI | Exit | BRAINSTORM CELL THERAPEUTICS | $0 | – | -400,000 | -100.0% | -0.07% | – |
VXX | Exit | BARCLAYS BANK IPATH SandP 500 VIX SHORT TERM FUTURES ETN EXP | $0 | – | -41,000 | -100.0% | -0.07% | – |
MDCO | Exit | MEDICINES CO PUT 32 04/21/2017put | $0 | – | -200,000 | -100.0% | -0.08% | – |
Exit | NEURODERM | $0 | – | -57,825 | -100.0% | -0.09% | – | |
PFE | Exit | PFIZER | $0 | – | -55,000 | -100.0% | -0.13% | – |
MYOV | Exit | MYOVANT SCIENCES | $0 | – | -226,322 | -100.0% | -0.20% | – |
CELG | Exit | CELGENE | $0 | – | -26,000 | -100.0% | -0.21% | – |
COLL | Exit | COLLEGIUM PHARMACEUTICAL | $0 | – | -196,728 | -100.0% | -0.22% | – |
BCRX | Exit | BIOCRYST PHARMACEUTICALS | $0 | – | -1,330,240 | -100.0% | -0.60% | – |
ACOR | Exit | ACORDA THERAPEUTICS | $0 | – | -720,000 | -100.0% | -0.96% | – |
CLCD | Exit | COLUCID PHARMACEUTICALS | $0 | – | -641,364 | -100.0% | -1.66% | – |
EGRX | Exit | EAGLE PHARMACEUTICALS | $0 | – | -498,198 | -100.0% | -2.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D | 2024-03-20 |
SC 13G | 2024-03-14 |
SC 13G | 2024-03-11 |
SC 13G/A | 2024-03-06 |
SC 13D/A | 2024-03-01 |
SC 13G | 2024-03-01 |
SC 13D/A | 2024-02-29 |
13F-HR/A | 2024-02-26 |
SC 13G/A | 2024-02-23 |
4 | 2024-02-21 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.